Analysis ImmunityBio Shares Surge on Manufacturing Breakthrough for Cell Therapy
ImmunityBio Inc. saw its equity value jump approximately 9% in trading, reaching an intraday high of $8.66, following a significant announcement regarding its manufacturing capabilities. The biotech firm confirmed it...